CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium.
about
20-HETE and blood pressure regulation: clinical implications20-HETE mediates ozone-induced, neutrophil-independent airway hyper-responsiveness in mice20-hydroxy-5,8,11,14-eicosatetraenoic acid mediates endothelial dysfunction via IkappaB kinase-dependent endothelial nitric-oxide synthase uncoupling20-HETE-induced nitric oxide production in pulmonary artery endothelial cells is mediated by NADPH oxidase, H2O2, and PI3-kinase/Akt.The role of 20-HETE in androgen-mediated hypertension.P450 in the angiogenesis affair: the unusual suspect.The cytochrome P450 4A/F-20-hydroxyeicosatetraenoic acid system: a regulator of endothelial precursor cells derived from human umbilical cord bloodProtection by 20-5,14-HEDGE against surgically induced ischemia reperfusion lung injury in rats.20-HETE contributes to ischemia-induced angiogenesis.20-HETE is associated with unfavorable outcomes in subarachnoid hemorrhage patients20-HETE increases survival and decreases apoptosis in pulmonary arteries and pulmonary artery endothelial cellsMolecular mechanisms and cell signaling of 20-hydroxyeicosatetraenoic acid in vascular pathophysiology.Endothelial-specific CYP4A2 overexpression leads to renal injury and hypertension via increased production of 20-HETE.Clinical Implications of 20-Hydroxyeicosatetraenoic Acid in the Kidney, Liver, Lung and Brain: An Emerging Therapeutic TargetThe cytochrome P450 pathway in angiogenesis and endothelial cell biology.Eicosanoids and their drugs in cardiovascular diseases: focus on atherosclerosis and stroke.Lung Circulation.20-HETE increases superoxide production and activates NAPDH oxidase in pulmonary artery endothelial cells.Nitric oxide contributes to 20-HETE-induced relaxation of pulmonary arteries.Expression of cytochrome P450 4A mRNA in mouse lung: effect of clofibrate and interleukin-1beta.Development of a new method for the isolation and culture of pulmonary arterial endothelial cells from rat pulmonary arteries.Hypoxic pulmonary vasoconstriction
P2860
Q28288942-15594C4F-7CAA-4FF8-991A-8FC50E96FE1BQ33565645-90C9358A-5CE3-4940-991B-68776CA8CA7AQ33574917-B600A4EA-A123-419E-B469-59FF3212709CQ33784118-1CAD5FF8-0A52-49C0-BBDA-6C259155E0DDQ34196923-5A2B35A2-8C22-48B2-AFFC-B74FD0E2501FQ35083598-EDEDA399-1EC2-4A5F-80C9-34C300D2EFCEQ35122891-1FA9D267-14E0-4AA1-AA82-4441CEFD9C04Q35710923-4132C6CD-7C4B-4ADD-9C7F-E4A2C48C5787Q35991539-8E0CF957-3B95-482C-A834-29C60452E538Q36267499-9E43DB3C-9266-4D08-8F27-B0D6EE80D382Q37138971-20161FCE-A40F-4F27-81B4-79741C890D80Q37340856-FF64D77E-D5AF-4ECB-A6A1-32E1B6E30B8DQ37417272-DF24626B-CA5D-4DE4-B158-D532F91AC56EQ37731230-D36709DD-0625-430E-BC1D-9B3358E4C332Q37947082-067964D2-69AB-43DE-B90C-39002FF3C087Q37995534-31D51900-588C-4A61-9BAB-F1DEA53B412FQ38804579-32688EC8-161F-4351-A0FF-592868139D4FQ42098014-EEC849B4-BBF6-4041-B4E2-73263D9851AFQ44138643-534AF67F-A28B-4007-9936-099598837267Q44831598-940B26F1-4335-4FBF-B327-FE6D078A2D83Q53676933-D032BAB9-C5C6-44C1-82ED-AC3A5F84F502Q57099542-0C76D02A-1682-486E-B102-7DB2BDE39B80
P2860
CYP4A mRNA, protein, and product in rat lungs: novel localization in vascular endothelium.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh
2002年學術文章
@zh-hant
name
CYP4A mRNA, protein, and produ ...... ation in vascular endothelium.
@en
CYP4A mRNA, protein, and produ ...... ation in vascular endothelium.
@nl
type
label
CYP4A mRNA, protein, and produ ...... ation in vascular endothelium.
@en
CYP4A mRNA, protein, and produ ...... ation in vascular endothelium.
@nl
prefLabel
CYP4A mRNA, protein, and produ ...... ation in vascular endothelium.
@en
CYP4A mRNA, protein, and produ ...... ation in vascular endothelium.
@nl
P2093
P2860
P1476
CYP4A mRNA, protein, and produ ...... ation in vascular endothelium.
@en
P2093
Chenyang Zhang
Daling Zhu
Elizabeth R Jacobs
Meetha Medhora
P2860
P304
P356
10.1152/JAPPLPHYSIOL.01159.2001
P407
P577
2002-07-01T00:00:00Z